A Clinical Study to Assess the Effect of Hair Care Products on Grey Hair and Overall Hair Health
NCT ID: NCT07123636
Last Updated: 2025-08-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
70 participants
INTERVENTIONAL
2023-11-01
2024-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Single-Group Clinical Trial Investigating the Effects of a Hair Vitamin Combination on Hair Growth and Hair Health
NCT06120933
Minoxidil for Treating White Hair: A Randomized Controlled Trial
NCT06813963
Proof-of-Science, Prospective, Interventional, Three-arm, Double-Blind, Randomized, Safety and Efficacy Real World Evidence Study.
NCT06552039
The Effects of an Oral Hair Supplement on Hair Density, Growth, and Microbiome
NCT06146166
A Clinical Trial to Examine the Efficacy of a Supplement to Support Healthy Hair and Skin
NCT06579742
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Hair Care Products
All participants will receive the four products and use them as directed over 24 weeks.
Hair Care Products
Daily oral intake of 2 tablets (Not Today, Grey). Twice-daily application of 3-4 pumps of "To The Root" serum. Wash and Smooth used according to hair type (daily or every other day).
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Hair Care Products
Daily oral intake of 2 tablets (Not Today, Grey). Twice-daily application of 3-4 pumps of "To The Root" serum. Wash and Smooth used according to hair type (daily or every other day).
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Aged 25-55
* Must experience 5-25% of hair being grey as confirmed by a dermatologist grading of the baseline photo (see Figure 1 below)
* Any hair color that the investigator can clearly distinguish grey hairs from the natural hair color.
* Individuals who have not dyed or highlighted their hair for at least 6 months prior to screening/baseline and who agree to refrain from dyeing the hair until after the final study visit.
* Willing to maintain the same hairstyle and length.
* Willing to refrain from using any topical hair products (other than Wash, Smooth, and To The Root) or treatments on the hair that could affect hair properties (e.g., heat treatments other than blowdrying, medicated shampoo) for the duration of the study.
* Willing to refrain from taking any vitamins, minerals, or herbal supplements with claims related to hair growth or benefits during the study and to not start taking any new vitamins, minerals, or supplements of any kind during the study.
* Willing to comply with the protocol, take all required photos, and immediately report any changes in health status or medications, adverse events, symptoms, or reactions.
* Willing and able to provide written informed consent, including an agreement to privacy language compliant with country and/or local requirements, after the scope and nature of the investigation have been explained and before the initiation of any study-related procedures.
* Must have a recent smartphone (iPhone 11 pro or greater/android equivalent).
Exclusion Criteria
* Anyone pregnant, trying to conceive, or breastfeeding.
* Anyone unwilling to follow the protocol.
* Anyone currently participating in another research study.
* Anyone with any known severe allergic reactions or with any allergies of any severity to any of the test product's ingredients (e.g., sesame).
* Anyone with a medical history of any condition that results in grey hair (for example, nutritional deficiencies, such as B12, iron, and copper deficiency, severe protein malnutrition, cystic fibrosis, celiac disease, hyperthyroidism/hypothyroidism, vitiligo, alopecia areata, and genetic diseases such as Werner syndrome, Louis-Bar syndrome, Waardenburg syndrome, or Griscelli syndrome).
* Having a medical history of any condition that results in hair darkening (e.g., Addison's disease, neurodermatitis, porphyria cutanea tarda, and inflammatory scalp conditions).
* Anyone currently receiving iron injections.
* Anyone who is currently a smoker or has smoked regularly in the last six months.
* Anyone who has a history of substance abuse (i.e., within six months prior to screening).
* Anyone who has started long-term medication within the last two months.
* Anyone who is having any planned surgeries or invasive procedures during the study period (24 weeks) or has undergone an invasive procedure three weeks prior to the study start.
* Anyone who has used an investigational drug or device within the 30 days prior to screening.
* Anyone who is currently undergoing hormone therapy (e.g., HRT, or testosterone) and anyone who in the last three months has undergone hormone therapy.
25 Months
55 Months
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Citruslabs
INDUSTRY
Two Lines LLC
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Citruslabs
Las Vegas, Nevada, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20385
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.